tiprankstipranks
Trending News
More News >
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
US Market

BridgeBio Pharma (BBIO) Income Statement

Compare
1,453 Followers

BridgeBio Pharma Income Statement

Last quarter (Q4 2025), BridgeBio Pharma's total revenue was $154.18M, an increase of 2521.22% from the same quarter last year. In Q4, BridgeBio Pharma's net income was $-197.24M. See BridgeBio Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 502.08M$ 221.90M$ 9.30M$ 77.65M$ 69.72M
Gross Profit
$ 473.81M$ 218.02M$ 6.86M$ 74.21M$ 66.60M
Operating Expenses
$ 1.04B$ 811.00M$ 614.23M$ 586.42M$ 643.23M
Depreciation and Amortization
$ 9.00M$ 6.08M$ 6.49M$ 6.77M$ 5.84M
EBITDA
$ -672.88M$ -436.83M$ -565.47M$ -397.44M$ -533.83M
Operating Income
$ -569.09M$ -592.97M$ -607.37M$ -512.20M$ -576.63M
Other Income/Expenses
$ -165.90M$ 50.78M$ -45.88M$ 27.55M$ -9.82M
Pretax Income
$ -734.99M$ -542.19M$ -653.25M$ -484.65M$ -586.45M
Net Income
$ -729.31M$ -535.76M$ -643.20M$ -481.18M$ -562.54M
Per Share Metrics
Basic EPS
$ -3.79$ -2.88$ -3.95$ -3.35$ -3.90
Diluted EPS
$ -3.79$ -2.88$ -3.95$ -3.35$ -3.90
Weighted Average Shares Outstanding
197.24M 186.08M 162.79M 147.47M 144.36M
Weighted Average Shares Outstanding (Diluted)
197.24M 186.08M 162.79M 147.47M 144.36M
Currency in USD

BridgeBio Pharma Earnings and Revenue History